331 related articles for article (PubMed ID: 23897011)
1. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.
Blits M; Jansen G; Assaraf YG; van de Wiel MA; Lems WF; Nurmohamed MT; van Schaardenburg D; Voskuyl AE; Wolbink GJ; Vosslamber S; Verweij CL
Arthritis Rheum; 2013 Nov; 65(11):2791-802. PubMed ID: 23897011
[TBL] [Abstract][Full Text] [Related]
2. Reduced folate carrier 1 gene expression levels are correlated with methotrexate efficacy in Japanese patients with rheumatoid arthritis.
Tazoe Y; Hayashi H; Tsuboi S; Shioura T; Matsuyama T; Yamada H; Hirai K; Tsuji D; Inoue K; Sugiyama T; Itoh K
Drug Metab Pharmacokinet; 2015 Jun; 30(3):227-30. PubMed ID: 26003891
[TBL] [Abstract][Full Text] [Related]
3. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
Stamp LK; Hazlett J; Highton J; Hessian PA
J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
[TBL] [Abstract][Full Text] [Related]
4. Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.
de Rotte MC; de Jong PH; Pluijm SM; Calasan MB; Barendregt PJ; van Zeben D; van der Lubbe PA; de Sonnaville PB; Lindemans J; Hazes JM; de Jonge R
Arthritis Rheum; 2013 Nov; 65(11):2803-13. PubMed ID: 24166792
[TBL] [Abstract][Full Text] [Related]
5. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
6. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
7. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
[TBL] [Abstract][Full Text] [Related]
8. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction.
Constantin A; Loubet-Lescoulié P; Lambert N; Yassine-Diab B; Abbal M; Mazières B; de Préval C; Cantagrel A
Arthritis Rheum; 1998 Jan; 41(1):48-57. PubMed ID: 9433869
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.
Nakashima-Matsushita N; Homma T; Yu S; Matsuda T; Sunahara N; Nakamura T; Tsukano M; Ratnam M; Matsuyama T
Arthritis Rheum; 1999 Aug; 42(8):1609-16. PubMed ID: 10446858
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.
Parker A; Izmailova ES; Narang J; Badola S; Le T; Roubenoff R; Ginsburg GS; Maier A; Coblyn JS; Shadick NA; Weinblatt ME
J Rheumatol; 2007 Sep; 34(9):1817-22. PubMed ID: 17696278
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis.
Dervieux T; Greenstein N; Kremer J
Arthritis Rheum; 2006 Oct; 54(10):3095-103. PubMed ID: 17009228
[TBL] [Abstract][Full Text] [Related]
13. Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients.
Samara SA; Irshaid YM; Mustafa KN
Int J Clin Pharmacol Ther; 2014 Sep; 52(9):746-55. PubMed ID: 25074866
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy.
Inoue K; Yuasa H
Drug Metab Pharmacokinet; 2014; 29(1):12-9. PubMed ID: 24284432
[TBL] [Abstract][Full Text] [Related]
15. Folate transport in mouse cumulus-oocyte complexes and preimplantation embryos.
Kooistra M; Trasler JM; Baltz JM
Biol Reprod; 2013 Sep; 89(3):63. PubMed ID: 23904512
[TBL] [Abstract][Full Text] [Related]
16. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
[TBL] [Abstract][Full Text] [Related]
18. 677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.
Kurzawski M; Pawlik A; Safranow K; Herczynska M; Drozdzik M
Pharmacogenomics; 2007 Nov; 8(11):1551-9. PubMed ID: 18034620
[TBL] [Abstract][Full Text] [Related]
19. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
Berkun Y; Abou Atta I; Rubinow A; Orbach H; Levartovsky D; Aamar S; Arbel O; Dresner-Pollak R; Friedman G; Ben-Yehuda A
J Rheumatol; 2007 Aug; 34(8):1664-9. PubMed ID: 17611986
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
